摘要
急性ST段抬高型心肌梗死是心血管疾病中的急危重症,再灌注治疗是首要治疗方法,再灌注损伤是常见并发症之一。心肌内出血是最近发现的一种再灌注损伤,与急性ST段抬高型心肌梗死患者预后不良密切相关。目前人们对心肌内出血的认识不充分,现结合国内外最新文献,对心肌内出血的危险因素、病理机制、预后、诊断和防治等进行综述,为进一步理解心肌内出血提供参考。
Acute ST-segment elevation myocardial infarction(STEMI)is an acute and severe cardiovascular disease.It is primarily treated with reperfusion therapy,and reperfusion injury is one of the common complications.Intramyocardial hemorrhage is a recently found reperfusion injury,which is closely related to the poor prognosis of patients with acute STEMI.At present,people’s understanding of intramyocardial hemorrhage is insufficient.Therefore,combined with the latest literature at home and abroad,this paper reviews the risk factors,pathological mechanism,prognosis,diagnosis,prevention and treatment of intramyocardial hemorrhage,so as to provide reference for further understanding of intramyocardial hemorrhage.
作者
刘丽芳
彭瑜
张钲
LIU Lifang;PENG Yu;ZHANG Zheng(The First Clinical Medical College,Lanzhou University,Lanzhou 730000,Gansu,China;Heart Center,The First Hospital of Lanzhou University,Key Laboratory of Cardiovascular Diseases of Gansu Province,Lanzhou 730000,Gansu,China)
出处
《心血管病学进展》
CAS
2022年第5期444-449,共6页
Advances in Cardiovascular Diseases
基金
科技部国家重点研发计划项目(2018YFC1311505)
甘肃省心血管疾病重点实验室建设项目(1206RTSA025)
甘肃省心血管病临床医学研究中心资助项目(甘科技〔2018〕20号)
2020兰州大学中央高校基本科研专项资金(lzujbky-2020-kb18)。
关键词
急性ST段抬高型心肌梗死
缺血再灌注损伤
心肌内出血
ST-segment elevation myocardial infarction
Ischemia reperfusion injury
Intramyocardial hemorrhage
